TY - JOUR
T1 - A content analysis of HPV vaccination messages available online
AU - Calo, William A.
AU - Gilkey, Melissa B.
AU - Malo, Teri L.
AU - Robichaud, Meagan
AU - Brewer, Noel T.
N1 - Funding Information:
Dr. Brewer has received commercial research grants from Merck and Pfizer and served as a paid advisory board member for Merck. He is chair of the National HPV Vaccination Roundtable which is funded by CDC and hosted by the American Cancer Society . The other authors have no financial disclosures or potential conflicts of interest to report.
Funding Information:
We thank Susan Alton Dailey, Karen Todd, Jonathan Yun, and Sarah Letchworth for their contributions in the early stages of this work. This study was supported by the CDC through cooperative agreement U48DP005017 (SIP 16-005). The content is solely the responsibility of the authors and does not necessarily represent the official views of the CDC.
Publisher Copyright:
© 2018 Elsevier Ltd
Copyright:
Copyright 2019 Elsevier B.V., All rights reserved.
PY - 2018/11/26
Y1 - 2018/11/26
N2 - Parents have varied HPV vaccine communication needs, which presents a challenge for healthcare providers. To improve communication resources for providers, we sought to characterize HPV vaccination messages available in existing educational materials. In fall 2016, we searched PubMed, educational material clearinghouses, and Google for English language HPV vaccination messages. We extracted messages that a provider might use when raising the topic of HPV vaccination, answering common questions, and motivating vaccination. Two reviewers independently coded each message. The search identified 267 unique messages about HPV vaccination. Messages generally were long (mean no. of words = 44, standard deviation [SD] = 33) and required a high level of education to read (mean reading grade level = 10, SD = 3). Only 32% of messages were shorter than 25 words, and 12% had a readability at or below grade 6. Most frequent were messages to address common parent questions or concerns (62%); the most common topics were diseases prevented by HPV vaccine (18%) and safety and side effects (16%). Many messages included information about cancer prevention (26%) and same-day vaccination (13%). Few messages (6%) used a presumptive style to recommend HPV vaccination. In conclusion, available messages about HPV vaccination were markedly varied. We identified few messages that were both brief (to facilitate providers memorizing them) and accessible (to facilitate parents understanding them). Future research should identify which messages lead to HPV vaccine uptake.
AB - Parents have varied HPV vaccine communication needs, which presents a challenge for healthcare providers. To improve communication resources for providers, we sought to characterize HPV vaccination messages available in existing educational materials. In fall 2016, we searched PubMed, educational material clearinghouses, and Google for English language HPV vaccination messages. We extracted messages that a provider might use when raising the topic of HPV vaccination, answering common questions, and motivating vaccination. Two reviewers independently coded each message. The search identified 267 unique messages about HPV vaccination. Messages generally were long (mean no. of words = 44, standard deviation [SD] = 33) and required a high level of education to read (mean reading grade level = 10, SD = 3). Only 32% of messages were shorter than 25 words, and 12% had a readability at or below grade 6. Most frequent were messages to address common parent questions or concerns (62%); the most common topics were diseases prevented by HPV vaccine (18%) and safety and side effects (16%). Many messages included information about cancer prevention (26%) and same-day vaccination (13%). Few messages (6%) used a presumptive style to recommend HPV vaccination. In conclusion, available messages about HPV vaccination were markedly varied. We identified few messages that were both brief (to facilitate providers memorizing them) and accessible (to facilitate parents understanding them). Future research should identify which messages lead to HPV vaccine uptake.
UR - http://www.scopus.com/inward/record.url?scp=85055156418&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85055156418&partnerID=8YFLogxK
U2 - 10.1016/j.vaccine.2018.10.053
DO - 10.1016/j.vaccine.2018.10.053
M3 - Article
C2 - 30366803
AN - SCOPUS:85055156418
SN - 0264-410X
VL - 36
SP - 7525
EP - 7529
JO - Vaccine
JF - Vaccine
IS - 49
ER -